These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11745203)

  • 1. Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era: implications for screening a high-risk group for prostate carcinoma.
    Paquette EL; Connelly RR; Sesterhenn IA; Zhang W; Sun L; Paquette LR; Greenspan R; McLeod DG; Moul JW
    Cancer; 2001 Nov; 92(10):2673-9. PubMed ID: 11745203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of extracapsular extension and positive margins in African American and white men.
    Paquette EL; Connelly RR; Sun L; Paquette LR; Moul JW
    Urol Oncol; 2003; 21(1):33-8. PubMed ID: 12684125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.
    Sanchez-Ortiz RF; Troncoso P; Babaian RJ; Lloreta J; Johnston DA; Pettaway CA
    Cancer; 2006 Jul; 107(1):75-82. PubMed ID: 16736511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
    Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
    J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.
    Freedland SJ; Jalkut M; Dorey F; Sutter ME; Aronson WJ
    Urology; 2000 Jul; 56(1):87-91. PubMed ID: 10869631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
    Eastham JA; Carver B; Katz J; Kattan MW
    Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
    Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.
    Deka R; Parsons JK; Simpson DR; Riviere P; Nalawade V; Vitzthum LK; Kader AK; Kane CJ; Rock CS; Murphy JD; Rose BS
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):581-588. PubMed ID: 32327702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
    Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
    BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
    Eastham JA; Kattan MW
    J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans.
    Caire AA; Sun L; Polascik TJ; Albala DM; Moul JW
    BJU Int; 2010 Oct; 106(8):1157-60. PubMed ID: 20367635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
    Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ
    J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males.
    Iselin CE; Box JW; Vollmer RT; Layfield LJ; Robertson JE; Paulson DF
    Cancer; 1998 Dec; 83(11):2353-60. PubMed ID: 9840535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer screening in Tyrol, Austria: experience and results.
    Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
    Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels.
    Freedland SJ; Aronson WJ; Kane CJ; Terris MK; Presti JC; Trock B; Amling CL
    Cancer; 2004 Aug; 101(4):748-53. PubMed ID: 15305405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.
    Wood HM; Reuther AM; Gilligan TD; Kupelian PA; Modlin CS; Klein EA
    J Urol; 2007 Oct; 178(4 Pt 1):1271-6. PubMed ID: 17698101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.